THE CLINICAL, LABORATORY CHARACTERISTICS AND TREATMENT OUTCOMES OF BENIGN PROSTATIC HYPERPLASIA BY HIGH-INTENSITY FOCUSED ULTRASOUND AT CAN THO UNIVERSITY OF MEDICINE AND PHARMACY HOSPITAL
Main Article Content
Abstract
Background: Benign prostatic hyperplasia is a common disease in men, it causes urinary tract disorders that affects to patients’s quality of life. Currently, high-intensity focused ultrasound is a breakthrough in the treatment of benign prostatic hyperplasia. This is an effective, minimally invasive, and relatively safe treatment. In Can Tho city, there are not many studies so that we have proceeded this research. Objectives: To describe clinical, laboratory characteristics and treatment outcomes of benign prostatic hyperplasia by high-intensity focused ultrasound at Can Tho University of Medicine and Pharmacy Hospital. Materials and methods: a prospective, crosssectional study was conducted on 35 patients with benign prostatic hyperplasia that were treated by high-intensity focused ultrasound method at Can Tho University of Medicine and Pharmacy Hospital, from 3/2019 to 7/2021. Results: 35 patients having a mean age of patients was 70,5±11,2 years old. The mean IPSS score was 23.7±5.8. The quality of life (QoL) score was 3.9±0.9. The mean prostate volume was 48±21.8ml. After 1 month of treatment, IPSS score (23,7 decrease to 21,6) and QoL (3,9 decrease to 3,6) score was more improved than pre-treatment. Maximum flow rate was more increased than pre-treatment (10.5ml/s to 11.8ml/s). Good and fair treatment results was 80%. Conclusion: The High-Intensity Focused Ultrasound System (HIFU) is a safe, effective, minimally invasive treatment for benign prostatic hyperplasia.
Article Details
Keywords
benign prostatic hyperplasia, high-intensity focused ultrasound system
References
2. Lê Quang Trung, Nguyễn Văn Đối, Phạm Việt Mỹ, Lê Thanh Bình, Đàm Văn Cương (2019), "Kết quả điều trị 80 trường hợp rối loạn đường tiểu dưới do tăng sinh lành tính tuyến tiền liệt bằng hệ thống siêu âm hội tụ cường độ cao tại Bệnh viện Trường Đại học Y Dược Cần Thơ", Tạp chí Y Dược học Cần Thơ, 22-25, tr. 342-348.
3. Ebert T, Miller S, Graefen M, Saddeler D, Schmitz-Dräger B, Ackermann R (1995 ), "Highintensity focused ultrasound (HIFU) in the treatment of benign prostatic hyperplasia (BPH)", Keio J Med, 44(4), pp. 146-9. doi: 10.2302/kjm.44.146.
4. Kok Bin Lim (2017), "Epidemiology of clinical benign prostati hyperplasia", Asian Journal of Urology, 4, pp. 148-151.
5. Stephan Madersbacher, Martin Susani, Christian Kratzik, Michael Marberger (1994), "Tissue ablation in benign prostatic hyperplasia with high intensity focused ultrasound", The journal of urology, 152, pp. 1956-1961.
6. Stephan Madersbacher, Bob Djavan, Georg Schatzl, Thomas Stulnig, Michael Marberger (2000), "Long-term outcome of transrectal highintensity focused ultrasound therapy for benign prostatic hyperplasia", Eur Urol, 37, pp. 687-694.
7. Mulligan ED, Mulvin D Lynch TH, Greene D, Smith JM, Fitzpatrick JM. (1997 ), "Highintensity focused ultrasound in the treatment of benign prostatic hyperplasia", Br J Urol, 79(2), pp. 177-180. doi: 10.1046/j.1464-410x.1997.03286.x. PMID: 9052466.
8. Toyoaki Uchida, Hisataka Kyunou, Masatoshi Muramoto, Masatsugu Iwamura, Shin Egawa, Ken Koshiba (1998), "Clinical outcome of high-intensity focused ultrasound for treating benign prostatic hyperplasia: Preliminary report", Adult urology, 52(1), pp. 66-71.